learn.howToCalculate

learn.whatIsHeading

The Tirzepatide Dose Calculator determines the appropriate weekly dose of tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) based on your titration phase. Tirzepatide is a dual GIP/GLP-1 receptor agonist with a unique six-step titration schedule reaching up to 15 mg per week.

सूत्र

Weekly Dose (mg) = Titration Step Dose × 1 injection/week

D: Current Dose (mg/week) — Prescribed weekly dose of tirzepatide
S: Titration Step (1-6) — Current step in the dose escalation sequence
W: Weeks on Treatment (weeks) — Total weeks since starting tirzepatide
V: Injection Volume (mL) — Volume per injection (0.5 mL for all doses)

चरण-दर-चरण मार्गदर्शिका

1Select your tirzepatide brand (Mounjaro or Zepbound) and weeks since initiation
2The calculator identifies your current titration step and corresponding dose
3View your current pen strength and the next scheduled dose increase
4Check dose adjustment recommendations if experiencing tolerability issues

हल किए गए उदाहरण

इनपुट

Mounjaro, week 14 of treatment

परिणाम

Current dose: 10 mg/week (Step 4 of 6). Using 10 mg/0.5 mL pen. Next increase to 12.5 mg at week 17 if needed for glycemic control.

इनपुट

Zepbound, week 22 of treatment

परिणाम

Current dose: 15 mg/week (Step 6, maintenance). Using 15 mg/0.5 mL pen. Maximum dose reached — continue indefinitely.

सामान्य गलतियां जिनसे बचना है

✕Not recognizing that tirzepatide has 6 available doses (2.5, 5, 7.5, 10, 12.5, 15 mg) vs. semaglutide's 5
✕Attempting to split or combine pens to create intermediate doses — each pen is single-use
✕Skipping the 2.5 mg starting dose, which is the required initiation dose regardless of patient weight

अक्सर पूछे जाने वाले प्रश्न

What makes tirzepatide different from semaglutide?

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two incretin hormone receptors instead of one. This dual mechanism appears to produce greater weight loss (up to 20.8% in trials) and comparable or superior A1C reduction compared to semaglutide, which only targets the GLP-1 receptor.

Can I stay on a lower dose of tirzepatide if it is working?

Yes. Unlike the titration schedule which must be followed during dose escalation, your maintenance dose can be 5, 10, or 15 mg depending on your clinical response. If you achieve adequate weight loss or glycemic control at 10 mg, your provider may keep you there rather than escalating to 15 mg.

learn.ctaText

इसे स्वयं आज़माएँ →